Artivion (AORT) Tops Q1 EPS by 18c ; Offers Guidance

Artivion (NYSE: AORT) reported Q1 EPS of $0.06, $0.18 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $97.4 million versus the consensus estimate of $92.05 million.

GUIDANCE:

Artivion sees FY2024 revenue of $386-396 million, versus the consensus of $388 million.
Additionally, Artivion continues to expect non-GAAP adjusted EBITDA to increase between 26% and 34% for the full year 2024 compared to 2023, resulting in 2024 non-GAAP adjusted EBITDA in the range of $68 to $72 million.

For earnings history and earnings-related data on Artivion (AORT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c